The COVID-19 Risk Communication Package for Healthcare Facilities, 20 March 2020
MetadataShow full item record
Other Language Versions
This package provides healthcare facility management and healthcare workers with an overview of the key actions required to keep safe and healthy in the workplace. This toolkit was originally developed by the World Health Organization’s Western Pacific Regional Office (WPRO).World Health Organization. Regional Office for the Western Pacific. (2020). The COVID-19 risk communication package for healthcare facilities. Manila : WHO Regional Office for the Western Pacific. https://apps.who.int/iris/handle/10665/331140. License: CC BY-NC-SA 3.0 IGO
Link to WHO's original document
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Respiratory Protection Program for Healthcare Workers Pan American Health Organization; Health Emergencies (PHE) (Washington, D.C., PAHO, 2023-01-03)Healthcare facilities contain airborne contaminants that can put the health of healthcare workers at risk. Control measures are needed to eliminate or mitigate these risks. This training manual addresses aspects of a ...
Analysis of implementation outcomes of quality improvement initiatives in Haiti: the fingerprint initiative Demes, Joseph Adrien Emmanuel; Becerril-Montekio, Victor; Torres-Pereda, Pilar; Jasmin, Ernst Robert; Dube, Jean Geto; Coq, Jean Garcia; Nickerson, Nathan (2021-05-18)[ABSTRACT]. Objective. To assess the process and outcomes of the implementation of an electronic fingerprint initiative as part of quality improvement in three health facilities in the Northern Department of Haiti, in terms ...
Carcinogenic drug exposure among health-sector workers: the need for exposure assessment and surveillance Müller-Ramírez, Claudio; Almashat, Sammy; Gaitens, Joanna; McDiarmid, Melissa (2023-03-10)[ABSTRACT]. Antineoplastic drugs (ANDs) used for chemotherapy can cause secondary cancers in treated patients and can pose carcinogenic risks to health-sector workers anywhere along these drugs’ life cycle in a facility, ...